These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17333482)

  • 1. Lead-like, drug-like or "Pub-like": how different are they?
    Oprea TI; Allu TK; Fara DC; Rad RF; Ostopovici L; Bologa CG
    J Comput Aided Mol Des; 2007; 21(1-3):113-9. PubMed ID: 17333482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    J Comput Aided Mol Des; 2002; 16(5-6):325-34. PubMed ID: 12489682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    Mol Divers; 2002; 5(4):199-208. PubMed ID: 12549672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a difference between leads and drugs? A historical perspective.
    Oprea TI; Davis AM; Teague SJ; Leeson PD
    J Chem Inf Comput Sci; 2001; 41(5):1308-15. PubMed ID: 11604031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five.
    Stegemann S; Moreton C; Svanbäck S; Box K; Motte G; Paudel A
    Drug Discov Today; 2023 Feb; 28(2):103344. PubMed ID: 36442594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of theoretical methods of calculation of partition coefficients for selected drugs.
    Pyka A; Babuśka M; Zachariasz M
    Acta Pol Pharm; 2006; 63(3):159-67. PubMed ID: 20085219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing libraries with CNS activity.
    Ajay ; Bemis GW; Murcko MA
    J Med Chem; 1999 Dec; 42(24):4942-51. PubMed ID: 10585204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based approach to drug lead discovery: overview and advances in various techniques.
    Fattori D; Squarcia A; Bartoli S
    Drugs R D; 2008; 9(4):217-27. PubMed ID: 18588353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database.
    Tetko IV; Bruneau P
    J Pharm Sci; 2004 Dec; 93(12):3103-10. PubMed ID: 15514985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel chemical space exploration via natural products.
    Rosén J; Gottfries J; Muresan S; Backlund A; Oprea TI
    J Med Chem; 2009 Apr; 52(7):1953-62. PubMed ID: 19265440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.